| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |